BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)

CAPS Rating: 3 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Recs

0
Player Avatar TrackUltraLong (< 20) Submitted: 7/9/2012 1:00:41 AM : Underperform Start Price: $40.76 BMRN Score: -20.51

http://www.fool.com/investing/general/2012/07/05/3-stocks-near-52-week-highs-worth-selling.aspx

Report this Post Reply

Featured Broker Partners


Advertisement